Response Evaluation Criteria in Solid Tumors

Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial.

Ari J. Rosenberg, Nishant Agrawal, Alexander T. Pearson, Tanguy Y. Seiwert, Zhen Gooi, Elizabeth A. Blair, Daniel Thomas Ginat, Adam Howard, Jeffrey Chin, Sara Kochanny, Evgeny Izumchenko, Aditya Juloori, Daniel J. Haraf, Everett E. Vokes

Citations: 30 • 2021

Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions

Khaled Bousabarah, Oliver Blanck, Susanne Temming, Maria-Lisa Wilhelm, Mauritius Hoevels, Wolfgang W. Baus, Daniel Rueß, Veerle Visser‐Vandewalle, Maximilian I. Ruge, Harald Treuer, Martin Köcher

Citations: 29 • 2021

CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer

B.A. Jereczek-Fossa, Isa Bossi-Zanetti, R. Di Mauro, G. Beltramo, Laura Fariselli, Lorenzo Bianchi, Cristiana Fodor, Piero Fossati, G. Baroni, Roberto Orecchia

Citations: 28 • 2013

Robotic radiosurgery for the treatment of liver metastases

Rafael García, I. Santa-Olalla, José Luis López Guerra, Silvia M. Sánchez, Ignacio Azinovic

Citations: 3 • 2016